Epoetin alfa - Early Communication about an Ongoing Safety Review
This is a discussion on Epoetin alfa - Early Communication about an Ongoing Safety Review within the FDA News forum, part of the Industry News and Updates category; FDA has been made aware of preliminary safety findings from a clinical trial conducted in Germany investigating the use of ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
09-26-2008, 12:42 PM
|
|||
|
|||
Epoetin alfa - Early Communication about an Ongoing Safety Review
FDA has been made aware of preliminary safety findings from a clinical trial conducted in Germany investigating the use of epoetin alfa to treat acute ischemic stroke.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. | industry_news | FDA News | 0 | 08-22-2008 03:44 PM |
| FDA delays review of Eli Lilly’s would-be blockbuster | industry_news | Biotechnology News | 0 | 06-24-2008 04:17 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Re | industry_news | FDA News | 0 | 06-07-2008 07:30 PM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
| FDA Issues Early Communication about an Ongoing Review of Vytorin | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |